All Articles

The Middle East healthcare giant posts record profits and a $163M dividend, fueled by aggressive international acquisitions and a major bet on AI technology.

Facing a competitive market, Luotea appoints Hanna Inget as CCO to drive its 4-5% growth target by leveraging data, tech, and customer experience.

A 15-year pharma alliance expands to Austria, bringing advanced relief to cancer patients suffering from chemotherapy's debilitating side effects.

An award-winning Turkish theatre company makes its UK debut, using live radio drama techniques to bring a classic adventure to life for all ages.

Zoya Technologies unveils an autonomous AI clinic that operates without the cloud, promising to revolutionize healthcare in underserved regions worldwide.

Leading Italian publisher adopts The Washington Post's Arc XP platform, betting on AI and data to navigate a radically changing media landscape.

With a new CEO from Visa-acquired Featurespace and fresh private equity backing, Ripjar is escalating its AI-driven battle against global financial crime.

As AI Day 2026 approaches, Algolia's CTO is set to unveil how the company is merging search and conversation to lead a user experience revolution.

Leading manufacturer GEVORKYAN is launching its first ESOP, a strategic move to retain key talent and drive growth in the competitive powder metallurgy market.

A new German partnership aims to create variant-ready, room-temperature stable vaccines, moving beyond the limits of first-generation mRNA technology.

Global giant CSL taps Swiss biotech Memo Therapeutics in a landmark deal, signaling a major shift from plasma to lab-grown immunotherapies.

A Japanese innovator is turning discarded textiles into premium building materials, seeking global partners at EuroShop 2026 to scale its circular solution.

A new partnership aims to unlock a vital Swedish rare earth deposit, a project crucial for Europe's green goals but plagued by environmental hurdles.

Pulsar Helium's 100% success rate at its Topaz project hints at a vast new source of a rare isotope vital for national security and quantum computing.

Activist investor 3DIP alleges Toho Holdings created an “artificial emergency” to block engagement, igniting a battle over corporate governance in Japan.

Peijia Medical submits its innovative GeminiOne heart valve repair system for EU approval, signaling a new challenge to established players in the market.

The deal marks the final step in a major strategic overhaul for dsm-firmenich, which will now focus solely on its nutrition, health, and beauty businesses.

Median Technologies' eyonis® LCS gains landmark FDA clearance, promising to revolutionize early detection of the deadliest cancer with its AI-powered diagnostics.

A new subcutaneous autoinjector for Alzheimer's drug Leqembi could soon transform care for millions in China, moving treatment from hospital to home.

Coinbase is back at the big game, swapping its viral QR code for a sing-along. Is this a savvy play for mainstream hearts or a high-risk brand gamble?